ARS Pharmaceuticals (SPRY) Net Equity Issued and Repurchased (2020 - 2021)
ARS Pharmaceuticals (SPRY) reported Net Equity Issued and Repurchased of $54.8 million for Q4 2021, up 109712.0% on a YoY basis from N/an in Q4 2020, and up 109712.0% sequentially from -$50000.0 in Q4 2020.
ARS Pharmaceuticals (SPRY) Net Equity Issued and Repurchased (2020 - 2021) Analysis & Trends
ARS Pharmaceuticals (SPRY) has 2 years of Net Equity Issued and Repurchased data on file, last reported at $54.8 million in Q4 2021.
- For the quarter ending Q4 2021, Net Equity Issued and Repurchased rose 109712.0% year-over-year to $54.8 million; the trailing twelve-month figure through Dec 2021 stood at $174.4 million (up 13.76% YoY), and the FY2021 full-year result was $54.8 million, down 64.26% from the prior year.
- Net Equity Issued and Repurchased advanced to $54.8 million in Q4 2021, from -$50000.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $119.7 million in Q3 2020 to a low of -$50000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 141.90 Mn |
| 10 | ARS Pharmaceuticals | 595.78 Mn | 394.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 54.81 Mn |
| Dec 31, 2021 | 54.81 Mn |
| Dec 31, 2020 | -50,000.00 |
| Dec 31, 2020 | -50,000.00 |
| Sep 30, 2020 | 119.69 Mn |
| Sep 30, 2020 | 119.69 Mn |
| Jun 30, 2020 | 12.05 Mn |
| Jun 30, 2020 | 12.05 Mn |
| Mar 31, 2020 | 21.66 Mn |
| Mar 31, 2020 | 21.66 Mn |